BCRB 2018
Reduction of radiosensitivity differences : Potential therapeutic advantage when the tumor is radioresistant in comparison with healthy tissues
Tumor
Tumor
Healthy tissues
HT
Dose ( high LET) Surviving Fractions (%)
Dose (low LET) Surviving Fractions (%)
Potential therapeutic benefit due to the reduction of an unfavourable differential effect
ESTRO 2018
Made with FlippingBook - Online catalogs